Alternative Protein Sources for Mitigating Post-Weaning Diarrhea in Piglets: Mechanistic Links among Protein Digestibility, Gut Microbiota, and Intestinal Barrier Function and Immune Regulation ()
1. Introduction
Diarrhea and mortality are one of the most important gastrointestinal diseases in modern pig production which can affect piglet health, growth performance, feed efficiency and survival during the most critical period of development [1]-[3]. When piglets are weaned, they are facing abrupt changes in nutrition, environment, social structure and their digestive, microbial, immune and epithelia systems are not fully mature [4]-[6]. This reduction in feed consumption and digestive enzyme function also causes a reduction in the digestibility of the nutrients and adapts the gut, while the faster remodeling of the gut microbiota also causes loss of gut microbial stability and colonization resistance [2] [3] [7]. These disturbances render the intestine susceptible to disorders and enteric infection. Dietary protein is very important in this regard as piglets at weaning may not be able to digest and absorb all the protein fed to them efficiently [5] [8]. This protein and peptides entering the hindgut undigested serve as substrates for over-fermentation by the proteolytic bacteria and result in the production of ammonia, biogenic amines, indoles, phenols, and branched-chain fatty acids (BCFA) [9] [10]. These metabolites can disrupt the balance of the gut microbiome at higher levels and affect the function of the gut, which may help cause and maintain PWD [2] [11].
Soybean meal is the predominant plant-protein ingredient used in pig diets because of its relatively high protein content, broad availability, and generally favorable amino acid profile. However, its use at high inclusion levels during the early post-weaning period may be constrained by residual anti-nutritional factors and antigenic proteins, particularly trypsin inhibitors, glycinin, and β-conglycinin [12]. These compounds can interfere with proteolytic digestion, provoke hypersensitivity or inflammatory responses, impair intestinal morphology and barrier function, and ultimately reduce nutrient utilization in newly weaned piglets [13] [14]. Accordingly, the suitability of a protein ingredient for newly weaned piglets should be assessed beyond its crude protein content and amino acid composition, taking into account ileal amino acid digestibility, processing-related changes, residual antinutritional factors, effects on hindgut fermentation, and functional effects on intestinal physiology. At the same time, restrictions on antibiotic growth promoters and the phase-out of pharmacological zinc oxide in several production systems have intensified the search for nutritional interventions capable of maintaining intestinal health and growth performance after weaning [1] [15]. These developments have increased interest in alternative protein sources that may provide both nutritional value and functional benefits for post-weaning intestinal health.
In recent years, however, the use of new piglet nutrition has evolved beyond simply replacing conventional protein ingredients, and focused on the development of protein strategies optimized for improved protein functionality during the post-weaning transition, particularly in the gastrointestinal tract [16]. A desirable protein source should not only supply the piglets with a balanced mixture of digestible amino acids but also minimize the amount of undigested protein entering the hindgut, minimize the presence of antinutrients, maintain the integrity of the gut, maintain a stable and beneficial microbial ecosystem and regulate excessive inflammatory response [17]. These traits are now known to play a major role in gut health post-weaning as they affect multiple other biological functions that play a role in the development of PWD [18] [19]. Thus, dietary protein ingredients should be assessed in relation to nutritional quality and modulation of host-microbiota interface and intestinal homeostasis as well, considering both nutritional and functional aspects [1] [4] [6].
Dietary protein digestibility is an important factor that is affecting the post-weaning intestinal health since it affects the availability of amino acids to the piglet as well as the amount of undigested nitrogenous substrates entering the distal intestine. Therefore, protein source and quality may impact proteolytic fermentation in the hindgut, microbial community structure, intestinal barrier function and inflammatory responses. Therefore, protein selection is one of the possible nutritional interventions to minimize PWD risk [1] [2]. These biological functions are tightly interlinked and dietary protein affects gastrointestinal homeostasis via concerted actions on digestion, the gut microbiota, epithelial barrier function, and immune reactions [1] [2] [9].
Various alternative protein sources, including fermented soybean meal, spray-dried plasma, yeast-derived products, insect proteins and new ingredients (e.g., microalgae and novel legumes) have been studied for their ability to reduce post-weaning diarrhea [20]. But these positive effects are not fully coalesced throughout the literature. The majority of studies have assessed individual protein sources in isolation and/or only one biological outcome, such as growth performance, nutrient digestibility, and microbial composition, without considering these data in the context of the overall biological systems underlying intestinal homeostasis and PWD pathogenesis [18] [21] [22]. It is also challenging to determine the main protein source of protective effects, and to systematically compare the functional roles of different protein sources. This review aims to build an overall mechanistic overview of dietary protein sources and their association with intestinal health after weaning, by combining information on protein digestibility, large intestine fermentation, microbiota modulation, intestinal barrier integrity and immune regulation. This review provides a biological insight to understand the functional role of different protein sources to devise nutritional strategies to prevent digestive disorders after weaning weaned piglets.
Selection and Interpretation of Literature
This is a narrative and mechanism-oriented review and not a systematic review or meta-analysis. The four electronic databases are Google Scholar, PubMed, Web of Science and Scopus to conduct literature search. All publications from 2000 to 2026 were taken into account and particular focus was given to publications in the 2020-2026 period. Literature search targeted studies that examined alternative protein sources in weaned piglets and their association with nutrient digestibility, gut fermentation, microbial composition and function, epithelial barrier integrity, immune response and clinical diarrhea.
Feed trials and challenge experiments with piglets were given preference for efficacy evaluation of ingredients in primary feeding trials, while review articles and non-piglet experimental studies were only considered when they provided relevant mechanistic background. Evidence interpretation included consideration of study population, diet formulation, ingredient processing, and inclusion level, challenge conditions, outcome definitions, and directness of evidence. This was a narrative review so conclusions relied on consistency and biological relevance of available evidence and not quantitative meta-analysis.
2. Pathophysiology of Post-Weaning Diarrhea
Post-weaning diarrhea (PWD) is a multi-factorial syndrome resulting from a combination of dietary changes, feed intake, changes in gut maturation, microbial balance and pathogen exposure that exceed the piglet’s ability to maintain gut homeostasis. Experimental evidence shows that there are rapid changes in several functions of the villus and crypt architecture, brush-border enzyme activity, epithelial transport and permeability, as well as epithelial cytokine expression after weaning, that diminish digestive and absorptive efficiency and increase the vulnerability of the epithelium [23] [24]. The distal intestine is exposed to higher concentrations of incompletely digested nutrients, such as nutritional protein, under these conditions, which can modify the availability of substrates, the microbial biochemistry and the physicochemical parameters of the lumen. The results of controlled challenge studies indicate that low crude protein intake yields firmer feces and results in fewer PWD cases and indices of proteolytic fermentation, while high protein or high casein diets exacerbate diarrhea and alter gut microbiota. Therefore, enterotoxigenic Escherichia coli is considered to only be part of a wider range of interlinked mechanisms contributing to the development of PWD, including digestive insufficiency, microbial dysbiosis, epithelial barrier dysfunction and mucosal inflammation.
The proteins (from feed or endogenous source) that escape digestion in the small intestine are degraded in the hind gut by microbial proteases and peptidases, then the amino acids and peptides produced are used as building blocks for microbial biomass or are fermented via deamination, decarboxylation and other pathways. These reactions produce a heterogeneous set of metabolites such as ammonia, branched chain fatty acids, biogenic amines, hydrogen sulfide, indoles, phenols, skatole and p-cresol [25] [26]. The physiological effects of compounds are metabolite-, concentration-, and site-dependent; although some amino acid-derived products may exert signaling or metabolic functions at physiological concentrations, their excessive accumulation can disturb colonocyte energy metabolism, epithelial turnover, barrier integrity, and intestinal water and electrolyte transport [27]. High dietary protein intake generally increases the intestinal concentrations of several protein-derived metabolites and has been associated with altered microbial activity, mucosal inflammatory responses, reduced fecal consistency, and a greater risk of PWD [25]. However, proteolytic and saccharolytic fermentation should not be viewed as strictly opposing processes because their relative contributions depend strongly on the availability of fermentable carbohydrates and the carbon-to-nitrogen ratio of the digesta. Increasing fermentable carbohydrate availability can redirect nitrogen toward microbial protein synthesis and reduce several potentially harmful protein-derived metabolites, although ammonia alone is an insufficient indicator of the overall extent of protein fermentation [10]. Thus, the pathological significance of hindgut protein fermentation is determined less by fermentation itself than by the quantity, composition, and intestinal accumulation of the resulting metabolites. Experimental evidence shows that the two pathways may occur simultaneously and that their relationship is strongly influenced by digesta composition and the carbon-to-nitrogen ratio [10].
2.1. Microbiota Dysbiosis and Loss of Stability
During weaning, the intestinal microbiota also goes through a rapid ecological succession when milk nutrients are replaced by a more complex solid feed containing plant proteins, starch and non-digestible carbohydrates. This physiological transition should not in itself be considered as dysbiosis and only with acute change in the diet, a decrease in feed intake, environmental stress, exposure to a pathogen or immature host defense is it considered as dysbiosis [28] [29].
Importantly, there is no single universal microbial signature of PWD as microbiota response depends on age, diet, housing conditions, antimicrobial exposure, genotype and intestinal sampling site. However, piglets that are susceptible to or affected by diarrhea often have impaired microbial stability and fermentation function, and an increase in facultative anaerobic bacteria and pathobionts in the gut, especially of Enterobacteriaceae such as enterotoxigenic Escherichia coli [2]. Ecological opportunities for the attachment, proliferation, and enterotoxin production of pathogens increase, thereby weakening colonization resistance. Microbial dysbiosis and intestinal dysfunction could perpetuate each other during the post-weaning period: dysbiosis and changes in metabolite production can lead to intestinal barrier failure and inflammatory response of the mucosa, and intestinal barrier failure during weaning and inflammatory response of the mucosa can affect the stability of the intestinal microbial community [2] [30]. However, experimental data indicate that FMT early in life decreases diarrhea, enhances expression of tight junctions and reduces intestinal inflammation, suggesting that the microbiota is not just a by-product of the disease [30].
The decrease in feed intake and decrease in luminal stimulation during weaning contribute to a shortening of the villi, remodeling of the crypts, and decreased absorption [31]. However, there are different outcomes, namely, intestinal morphology and functional barrier integrity: recovery of villus architecture does not necessarily indicate that epithelial permeability or tight-junction regulation has normalized [32]. This enhanced permeability can allow the mucosal immune cells to come into contact with the dietary antigens and microbial products, which leads to cytokine and MAPK-mediated responses that may further impair epithelial transport and barrier function [23] [32] [33].
2.2. Intestinal Barrier Dysfunction and Mucosal Inflammation
The intestinal epithelial barrier is a dynamic defense system that includes the mucous barrier, epithelial continuous sheet, intercellular junctional complexes, antimicrobial secretions and underlying mucosal immune system components. In the immediate post-weaning period, lower feed intake, sharp dietary changes and lower luminal stimulation are all important factors that cause villus shortening, crypt remodeling, lower epithelial renewal and decreased absorptive capacity [31] [34]. In addition to these structural changes, transepithelial electrical resistance decreases, paracellular permeability increases, ion transport changes and tight junction proteins (e.g., zonula occludens-1, occluding, and claudins) expression and localization are altered. Weaning is therefore correlated with a rise in intestinal expression of pro-inflammatory cytokines, including interleukin 1 beta (IL-1β), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-α), as well as activation of stress-responsive signaling pathways, including nuclear factor kappa B (NFκB) and mitogen-activated protein kinases (MAPKs) [23] [32]. Barrier dysfunction and mucosal inflammation are in a vicious cycle: with barrier dysfunction leading to immune activation and vice versa, leading to increased susceptibility of weaned piglets to enteric infection and diarrhea.
2.3. ETEC Colonization and Enterotoxin-Mediated Secretory
Diarrhea
Enterotoxigenic Escherichia coli (ETEC) is an important infectious factor in the development of PWD, and requires successful colonization of the intestine and susceptibility of the host for disease development [35] [36]. In the case of porcine ETEC, fimbriae containing either F4 or F18 are frequently expressed, which bind to epithelial cells of the small intestine, and are followed by the production of heat-labile (LT) and/or heat-stable (STa and STb) enterotoxins [37]-[39]. These toxins induce secretory diarrhea through the cAMP-, cGMP- and calcium-associated signaling pathways, which disrupt intestinal ion transport leading to secretion of electrolytes and water [37] [40]. ETEC infection also may disrupt the integrity of the tight junctions and induce inflammation of the mucosa, which would further exacerbate the intestinal dysfunction observed during weaning [35] [41]. Thus, the diarrhea is not just due to gross mucosal destruction but mainly secretory. However, it may also affect tight-junction organization, affect epithelial renewal, induce oxidative stress, and induce inflammatory responses of the mucosa, which may link the enterotoxin-mediated secretion with the underlying microbial, epithelial, and immune disturbances already present as a result of the weaning stress [35] [42].
2.4. Integrated Pathophysiological Cycle
The pathogenesis of post-weaning diarrhea is better conceptualized as a self-reinforcing biological network than as a simple linear sequence of events. After weaning, reduced feed intake, immature digestive capacity, and impaired nutrient absorption increase the delivery of undigested substrates to the distal intestine [4]. These substrates alter microbial community structure and fermentation activity, potentially promoting the expansion of enteric pathobionts and the accumulation of metabolites that impair epithelial function [2] [5]. The resulting inflammatory response further disrupts tight-junction organization, epithelial renewal, nutrient transport, and intestinal water and electrolyte homeostasis, thereby intensifying diarrhea and growth impairment [34]. The severity of clinical PWD depends on the interaction between pathogen exposure and the piglet’s nutritional, microbial, epithelial, and immunological status [42]. Consideration then must be given to gastrointestinal dysfunction that may be further enhanced by increased intestinal transit, nutrient loss, decreased appetite and delayed recovery of the gut lining. This integrated model accounts for why single target interventions on a single pathological process frequently yield variable results and why nutritional strategies that target multiple processes and/or have multiple functions might be more predictable [1].
It is now recognized that post-weaning diarrhea is a self-reinforcing disorder, made up of a combination of nutritional, microbial, epithelial, immunological and infectious events. The sudden removal from the sow, reduced feed consumption, change of feed and immaturity of gut function all impair the ability to hydrolyze and absorb nutrients, allowing more undigested protein (e.g., dietary protein and endogenous protein) to pass down into the distal gut [5] [34]. This change in substrate availability may further enhance the proteolytic fermentation, change the substrate-metabolite profile in the lumen and disrupt the structure of the microbial community, which consequently decreases colonization resistance and increases the opportunity for enteric pathobionts to proliferate [2].
Post-weaning diarrhea is a self-exacerbating condition where nutrition, microorganisms, epithelium, immune system and infectious diseases play a role [18] [43]. The decreased feed intake and digestive capacity of the animal around weaning lead to more undigested protein reaching the distal intestine and thus to more proteolytic fermentation and microbial instability [5] [18] [44]. This disruption of the barrier and increase in intestinal permeability can in turn increase the exposure of the mucosa to microbial products and dietary antigens and augment inflammatory responses that can further compromise epithelial integrity, nutrient transport, and intestinal recovery [2] [18] [45] [46]. Colonization by fimbriae, plus fluid and electrolyte secretion in response to ETEC can lead to this cycle [43] [47] [48]. Therefore, nutritional strategies to enhance performance should focus on several interconnected processes, such as protein digestibility, microbial stability, hindgut protein fermentation, maintenance of integrity of the epithelia and regulation of inflammation [45] [49]. Thus, evaluation of the ability of alternative protein sources to impact at one or more of these linked nodes should be done in addition to crude protein content and amino acid profiles.
The dietary, environmental, and physiological stressors involved in weaning lead to decreased digested efficiency, decreased intake of feed, dysbiosis of intestinal microbiota and impaired barrier integrity of the gut epithelial cells [23] [32]. Post-weaning microbial dysbiosis could include a decrease in microbial ecological stability, fermentation and colonization resistance, and a variable microbial profile between individual piglets and production environment [50]. The translocation of microbial products and dietary antigens that occurs due to villus atrophy, disruption of tight-junction proteins, and increased intestinal permeability is responsible for the activation of NF-κB- and MAPK-dependent inflammatory pathways. ETEC with F4 or F18 fimbriae bind to the small-intestinal epithelium and secrete heat-labile and heat-stable enterotoxins that disrupt cyclic nucleotide signaling, leading to chloride/bicarbonate secretion, decreased sodium absorption and secretory diarrhea [51]. These processes build up a vicious circle of sub-par digestion, overload of protein in the hindgut, proteolytic fermentation, microbial dysbiosis, barrier failure, inflammation, decreased feed intake and delayed intestinal recovery. Nutritional interventions can break the cycle by enhancing protein digestibility, minimizing the presence of antinutritional factors, limiting undigested protein in the hindgut, maintaining a stable gut microflora, maintaining integrity of the intestinal epithelium and reducing excessive inflammation [52].
Abbreviations used in the integrated model: BCFA, branched-chain fatty acids; cAMP, cyclic adenosine monophosphate; cGMP, cyclic guanosine monophosphate; ETEC, enterotoxigenic Escherichia coli; IL, interleukin; LT, heat-labile enterotoxin; MAPK, mitogen-activated protein kinase; NF-κB, nuclear factor kappa B; PWD, post-weaning diarrhea; STa and STb, heat-stable enterotoxins A and B; TNF-α, tumor necrosis factor alpha; ZO-1, zonula occludens-1.
3. Mechanistic Framework Linking Dietary Protein
Sources to Gut Health
The effect of dietary protein source on post-weaning intestinal health is determined by more than just its nutritional value; it requires a series of interrelated biological pathways. These processes include small intestinal protein digestibility, hind gut fermentation, microbiota composition and metabolic activity, epithelial barrier integrity and immune inflammatory regulation [2]. All these biological processes are not independent but interact with each other to decide the intestinal homeostasis and susceptibility to postweaning diarrhea (PWD). The integrated pathophysiological events underlying the pathogenesis of postweaning diarrhea in piglets are summarized in Figure 1 and the key nutritional intervention points are indicated at which alternative protein sources might have an effect on the complex chain of events.
Figure 1. Integrated pathophysiological mechanisms in post-weaning diarrhea in piglets and main nutrition intervention points.
The pathophysiological network summarized in Figure 1 serves as a basis for assessing alternative protein sources, based not only on nutrient composition, but also on biological function. In this context, the impact of dietary proteins on gut health after weaning can be classified into five interconnected mechanistic domains: small-intestinal protein digestibility, hindgut fermentation, composition and activity of the intestinal microbiota, integrity of the epithelial barrier and immune-inflammatory modulation [2].
Table 1 summarizes the major features and biologic roles of the five mechanistic domains. These domains are hierarchical and not autonomous. Digestion of dietary proteins in the small intestine affects the amount and biochemical composition of dietary proteins reaching the large intestine, whilst the products of microbial fermentation will affect the ecology, metabolism of epithelial cells, permeability of epithelia, and immune signaling [8] [9]. On the other hand, if the intestine becomes inflamed and damaged, the activity of digestive enzymes and the absorptive capacity may be lowered, causing an increase in overflow of nutrients and stimulating microbial fermentation.
A linear relationship between crude protein content, amino acid balance/clearly digestibility and incidence of diarrhea was not observed in this reciprocal organization. The mechanism of action of the protein ingredient may be direct, while that of another may be mediated by antimicrobial peptides, immunoglobulins, bioactive polysaccharides or other functional components [2] [5]. Alternative proteins should then be evaluated based on the “where”, “how much” and “how consistently” they make an impact, and if an impact on a biomarker is followed by a direct clinical impact, within the five mechanistic domains [2] [5].
Table 1. Mechanistic domains of the effects of dietary protein sources on post-weaning diarrhea in piglets.
Mechanistic
domain |
Protein-source
characteristics
involved |
Principal biological
processes |
Recommended biomarkers
and indicators |
Expected implication
for PWD |
Important
interpretive
limitation |
References |
Small-intestinal
protein
digestibility |
Protein structure and
solubility; peptide size;
amino acid
composition;
processing severity;
protease inhibitors;
antigenic proteins;
fiber content |
Gastric, pancreatic,
and brush-border
hydrolysis; peptide
and amino acid
absorption;
endogenous
amino acid losses |
Apparent ileal digestibility;
standardized ileal
digestibility; ileal
undigested nitrogen;
pancreatic and
brush-border enzyme
activities; plasma or
blood urea nitrogen |
May reduce the
amount of
undigested protein
reaching the
hindgut and limit
excessive
proteolytic
fermentation |
High digestibility
does not necessarily
indicate reduced
antigenicity,
improved barrier
protection, or
immunomodulatory
activity |
[52]-[54] |
Hindgut
protein
fermentation |
Ileal protein escape;
amino acid
composition;
endogenous protein
secretions; fermentable
carbohydrate supply;
digesta
carbon-to-nitrogen
ratio |
Microbial proteolysis,
deamination,
decarboxylation, and
aromatic amino acid
catabolism |
Ammonia; BCFAs; biogenic
amines; indoles; phenols;
skatole; p-cresol; hydrogen
sulfide; SCFAs; digesta pH |
May reduce
excessive
accumulation of
protein-derived
metabolites and
contribute to a
more balanced
hindgut
fermentation
environment |
Ammonia alone is
insufficient to
characterize
protein
fermentation;
metabolite effects
depend on
concentration,
intestinal site, and
interactions with
carbohydrate
fermentation |
[10] [55]
[56] |
Microbiota
composition
and
metabolic
function |
Substrate availability;
protein fermentability;
peptide profile;
residual carbohydrates;
organic acids;
fermentation-derived
compounds; microbial
or yeast cell-wall
components |
Microbial community
restructuring;
pathogen competition;
colonization
resistance; microbial
metabolite
production; functional
pathway regulation |
Alpha and beta diversity;
Enterobacteriaceae;
Escherichia-Shigella;
Lactobacillus; Prevotella;
metagenomic functions;
SCFAs; ammonia;
indoles; phenols; pathogen
load |
May support
microbial stability,
enhance colonization
resistance, and
reduce ecological
conditions favorable
for ETEC
proliferation |
Changes in individual
bacterial taxa should
not be classified as
beneficial or harmful
without
corresponding
functional, metabolic,
and host-response
data |
[56] [57] |
Intestinal
barrier
integrity |
Bioactive peptides;
immunoglobulins;
growth factors;
antioxidants;
antigenic proteins;
microbial metabolites;
fermentation products |
Epithelial renewal;
villus maintenance;
mucus production;
tight-junction
assembly; paracellular
permeability;
epithelial repair |
Villus height; crypt depth;
villus-height-to-crypt-depth
ratio; ZO-1; occludin;
claudins; mucins;
transepithelial electrical
resistance; FITC-dextran
permeability; serum
diamine oxidase; D-lactate |
May reduce epithelial
leakage and antigen
translocation and
contribute to reduced
susceptibility to
inflammatory and
secretory diarrhea |
Improvements in
morphology or
tight-junction-related
markers do not
necessarily indicate
complete restoration
of epithelial barrier
function unless
supported by
functional
permeability
measurements |
[32] [52]
[58] |
Immune and
inflammatory
regulation |
Immunoglobulins;
β-glucans; mannans;
bioactive peptides;
growth factors;
antigenic proteins;
antioxidant
compounds |
Pattern-recognition
receptor activation;
NF-κB and MAPK
signaling; cytokine
production; mucosal
antibody responses;
immune-cell
recruitment and
regulation |
IL-1β; IL-6; IL-8; IL-10;
TNF-α; interferon-γ;
NF-κB activation; MAPK
phosphorylation; secretory
IgA; IgG; IgM;
inflammatory-cell
infiltration |
May regulate
excessive mucosal
inflammation,
support immune
defense, and
contribute to
epithelial recovery |
Immune effects may
be direct or secondary
to changes in
digestibility,
microbiota,
fermentation
metabolites,
or intestinal
permeability |
[52] [58]
[59] |
Note: BCFA, branched-chain fatty acid; ETEC, enterotoxigenic Escherichia coli; FITC-dextran, fluorescein isothiocyanate-dextran; MAPK, mitogen-activated protein kinase; NF-κB, nuclear factor kappa B; PWD, post-weaning diarrhea; SCFA, short-chain fatty acid; ZO-1, zonula occludens-1. The mechanistic domains are biologically interconnected and should not be interpreted as independent pathways. Improvements in individual biomarkers should not be considered direct evidence of PWD prevention unless supported by integrated clinical, microbial, metabolic, epithelial, and immunological outcomes.
3.1. The Small-Intestinal Protein Digestibility Is an Upstream Regulatory Node
Intestinal digestibility is the first step and the first mechanism for dietary protein sources to impact post-weaning gut health. The digestibility of crude protein depends not only on its content, but also on the structure or solubility of proteins, amino acid composition, endogenous amino acid losses, the severity of the processing, and other nutrient inhibitors such as fiber, protease inhibitors, antigenic proteins, etc. [8]. Total-tract digestibility is less useful in amino acid evaluation than ileal digestibility because nitrogenous compounds may be altered by microbial metabolism after the ileum and this will not reflect the quantity of the amino acids of the dietary protein that are available for absorption by the host [60] [61]. The apparent ileal digestibility (AID) is the digestibility of dietary and endogenous amino acids in the digesta before they reach the terminal ileum, while the standardized ileal digestibility (SID) is the digestibility of dietary amino acids after the terminal ileum corrected for basal endogenous amino acid losses, which is more appropriate for comparing individual feed ingredients and for use in the formulation of mixed diets.
In ileal-cannulated weaned pigs, two fermented soybean meal formulations were able to improve the apparent and standard ileal digestibility of crude protein and amino acids and reduced the major antinutritional factors found in soybean meal [52]. Other comparisons have shown different results with one study finding good apparent ileal digestibility values for fermented soybean meal [62] and one more recent finding similar values for amino acid digestibility as compared to conventional soybean meal [63].
Higher ileal protein and amino acid digestibility may reduce the amount of undigested nitrogenous substrate reaching the hindgut and thereby limit the potential for excessive proteolytic fermentation [8]. However, digestibility alone does not establish gut-health efficacy, because protein ingredients may differ in antigenicity, bioactive components, microbial fermentability, and effects on epithelial barrier and immune function [52]. Ileal digestibility should therefore be interpreted together with fermentation, barrier, immune, and clinical outcomes when evaluating alternative protein sources for PWD mitigation.
3.2. Regulation of Hindgut Protein Fermentation
The remaining dietary and endogenous proteins in hind gut are hydrolyzed by microbial proteases/peptidases to peptides and amino acids which are then metabolized by deamination, decarboxylation and catabolism of aromatic amino acids. These reactions result in the production of ammonia, branched-chain fatty acids, biogenic amines, indoles, phenols, skatole, hydrogen sulfide and p-cresol, some of which can have negative effects on the metabolism and integrity of the epithelium when produced in too large quantities [9] [25]. High protein content in the diet and the use of poorly digestible protein ingredients tend to lead to higher N-substrate availability and thus to a more proteolytic fermentation profile, which can negatively affect the microbial composition, fecal consistency, epithelial metabolism and integrity and increases the risk of diarrhea in weaned piglets [11] [56].
Highly digestible sources of protein, or a proper reduction in dietary protein, can on the other hand reduce the amount of fermentable nitrogen reaching the hindgut, and the production of some of the potentially harmful metabolites [55] [64]. while retaining the level of essential amino acids. Fermentable carbohydrates are also involved in this process, as they provide microbial energy and stimulate the incorporation of nitrogen into microbial biomass, thus shifting metabolism towards saccharolytic fermentation and increasing the production of short-chain fatty acids, especially acetate, propionate and butyrate [10]. With this in mind, alternative protein sources must also be evaluated for their impact on hindgut substrate balance and the profile of microbial metabolites if effective control of PWD is to be achieved in order to minimize the amount of the harmful protein-derived products whilst maintaining the beneficial microbial fermentation.
3.3. Modulation of Microbiota Composition and Metabolic
Function
Protein source and processing method in the diet influence the gut microbial composition and fermentation in weaned piglets, but this is ingredient and context specific. In piglets challenged with ETEC, fermented soybean meal affected cecal microbiota, with a reduction in the abundance of Proteobacteria, Actinobacillus and Escherichia-Shigella bacteria, and with improved growth, fecal consistency and inflammatory profile [57]. Likewise, fermented corn-soybean meal boosted the levels of lactobacilli, faecalibacteria, and butyrate in the colon, and total replacement of the maize meal prevented diarrhea in the rats [65]. Thus, microbiota-related effects of alimentary protein sources should be considered in conjunction with microbial metabolites and host-health outcomes and not based on changes in individual microbiota taxa. Comparisons between fermented soybean meal, fish meal and a blend of the two also show that different protein sources can differently modify the ileal and colonic bacterial community, confirming that protein source affects microbiota responses and these responses are intestinal site specific [66].
3.4. Maintenance of Intestinal Barrier Integrity
The intestinal epithelial barrier is a key downstream point of convergence where dietary protein sources can contribute to either exacerbation or amelioration of PWD [2] [44]. Protein ingredients can affect barrier integrity indirectly by altering the quantity of undigested protein and antigenic compounds that reach the distal intestine and, subsequently, the production of microbial metabolites that are able to harm epithelial cells [11] [67]. They can also exert direct effect via the release of immunoglobulin, bioactive peptides, growth factors, antioxidants and fermentation-derived compounds that affect the proliferation of epithelium, mucosogenesis, tight-junction assembly and mucosal repair [15] [68]. The coordinated regulation of villus architecture, epithelial turnover, goblet cell activity, mucin production, and the expression of junctional proteins (e.g., zonula occludens-1, occludin, and claudins) is essential for maintenance of a functional barrier [69]. Therefore, villus height and villus-height to crypt-depth ratio should not be used alone as evidence of barrier restitution as structural restitution can occur before transepithelial resistance and paracellular permeability become normalized [32]. Thus, barrier assessment should include both histological and molecular markers and functional markers such as villus morphology, markers of mucin expression, markers of tight-junction abundance and localization, markers of transepithelial electrical-resistance, markers of macromolecular flux, serum D-lactate or diamine oxidase, and urine or serum markers of permeability.
Experimentally, it has been shown that different protein sources have different mechanisms of action in support of barrier integrity. Beyond its superior digestibility, SDPP has bioactive and immunological properties which can be beneficial in newly weaned pigs by promoting intestinal barrier function and limiting mucosal inflammation and diarrhea [58]. Soaked soy proteins could exert their effect both by decreasing antigenicity and by producing functional peptides. Fermented soybean meal and its peptide fractions have been linked to upregulation of mucin and tight-junction protein expression, a decrease in inflammatory and permeability markers in the blood, and an increase in resistance of piglets’ and porcine intestinal epithelial cells to intestinal permeability [70]. Like that, fermented corn-soybean meal decreased diarrhea, and improved intestinal barrier associated outcomes and microbial fermentation in weaned piglets, demonstrating the interaction between substrate processing, microbiota activity and protection of the intestinal barrier [65]. These results suggest that barrier protection can be achieved by multiple non-equivalent mechanisms: reducing exposure to soybean antigens and toxic fermentation products, providing bioactive molecules that strengthen epithelial barrier, facilitating the renewal of mucous membrane and epithelium, and inhibiting inflammation that could destabilize barrier. Alternative protein sources should thus be considered barrier-supportive if morphology and/or expression of tight-junctions improve and if possible, if morbidity due to diarrhea decreases.
3.5. Immune and Inflammatory Regulation
One of the most important downstream pathways by which dietary protein sources affect intestinal recovery and susceptibility to PWD is immune-inflammatory regulation [5]. Microbial dysbiosis, epithelial leakage, soybean derived antigens, and ETEC associated molecular signals can be recognized by pattern-recognition receptors and trigger downstream NF-κB and MAPK pathways and consequently increase inflammatory mediator production, including IL-1β, IL-6, IL-8, TNF-α and interferon-γ [32] [71]. While transient immune activation is indispensable for the defense against pathogens and the repair of tissues, an exaggerated or protracted immune activation leads to increased permeability of the epithelia, a change in intestinal secretion and absorption, and a shift in amino acids and energy from growth to immune function. Alternative protein sources can indirectly regulate this response by making the protein more digestible, by limiting exposure to antigenic proteins, by reducing toxic fermentation products and by stabilizing the composition of the microbiota, or directly by the presence of active components of the protein such as immunoglobulins, bioactive peptides, β-glucans, mannans, growth factors, or other functional components [71]. An example of a direct immunological activity could be the effects of spray dried porcine plasma on intestinal levels of TNF-α and interferon-γ, inflammatory-cell accumulation, and the integrity of the epithelia, and on fecal score in pigs just after weaning, as dietary inclusion of plasma resulted in clear coordinated effects on this mucosal immunity and barrier function that could not only be a purely nutritional response [58].
Fermented soybean meal may have a dual mechanism of reduced antigenicity and the production of bioactive compounds via the fermentation process; in weaned pigs, fermented soybean meal produced a higher serum IL-4, and higher levels of immunoglobulin A, G, and M, while decreasing the levels of IL-2 and IL-6, although the small experimental sample size and systemic rather than mucosal markers preclude direct inferences about protection against PWD [52]. A purified glucan from Saccharomyces cerevisiae and related yeasts appeared to have an effect on downregulating a number of pro- and anti-inflammatory cytokine transcripts in pig intestinal tissue and also reducing the levels of Enterobacteriaceae, although caution needs to be exercised when considering the immune equivalence of all yeast products owing to the different glucan structures, solubility, sources and dosages [59]. Therefore, the ideal goal is not to simply suppress the immune response but to restore immune homeostasis at the mucosal level, so that the immune response is adequate to control pathogens, and inflammation is controlled, preventing excessive inflammation that would worsen barrier disruption and diarrhea.
3.6. Integration of the Five Mechanistic Pathways
Small intestinal digestibility, hind gut fermentation, microbiota modulation, epithelial barrier integrity and immune-inflammatory regulation can be studied individually, but are believed to be an overwhelming connected biological network [2]. It is proposed that alternative protein sources interact with the major biological processes related to intestinal homeostasis, as summarized in Figure 2. The figure shows the relationship between protein digestibility, hindgut fermentation, regulation of the gut microbiota, integrity of the gastrointestinal barrier and immune-inflammatory responses. It also demonstrates that the impact of alternative proteins is not only through one pathway but by coordinated activities at nutritional, microbial, epithelial and immunological levels. The small intestinal protein utilization is the principal upstream control point which regulates nitrogenous matter flow and composition to the hind gut. However, digestibility is not the only factor which is influencing the gut-health response [72] [73]. In piglets fed a high protein diet, an increase in ammonia, branched-chain fatty acids, biogenic amines, indoles and phenols in the ileum due to undigested protein could affect the metabolism of the epithelium and cause diarrhea, which has been observed [56] [74]. When barrier function is damaged, it leads to increased exposure of the mucosal immune cells to microbes and food molecules, which further damages tight-junction structure, digestive function and nutrient uptake, causing more overflow of substrates and perpetuating the cycle [32]. There are several points in this network where alternative proteins can be used to disrupt it. In general, fermented soybean meal exerts its effects mainly upstream, by decreasing the presence of antinutritional factors and increase the digestion of nutrients; however, this can include the antioxidant activities, intestinal morphology and immune responses [52]. In addition to a high nutritional value, spray dried porcine plasma (SDPP) also harbours immunoglobulins and other bioactive ingredients that directly affect the level of inflammation at the mucosa, the permeability of the mucosa and the severity of the diarrhea [58]. Thus, evaluation of the efficacy of an alternative protein source should be performed in a hierarchically structured evidence framework that includes: 1) primary nutritional effects such as ileal digestibility and reduction in antinutritional factors; 2) intermediate mechanistic responses such as fermentation metabolites, microbiota function, epithelial permeability and immune signaling; and 3) clinically relevant outcomes such as incidence of diarrhea, fecal consistency, feed intake, growth rate and feed efficiency. This approach helps to prevent that efficacy is only credited to a single biomarker and helps to give a solid foundation to compare different protein sources later in this section. Alternate protein sources can affect various nodes in this biological network, presenting numerous opportunities to prevent intestinal dysfunction and promote post-weaning health as shown in Figure 2.
![]()
Figure 2. Proposed mechanisms by which alternative protein sources modulate intestinal digestion, microbiota, epithelial barrier integrity, and immune responses to alleviate post-weaning diarrhea in piglets.
4. Comparative Evaluation of Alternative Protein Sources
for PWD Mitigation
Now that the five mechanistic domains of how dietary protein can affect post-weaning gut health are known, alternative protein sources can be evaluated based on their predominant biological action(s), strength of evidence, and practicality, as well as crude protein concentration. The ileal digestibility, antinutritional-factor burden, bioactive-component composition, fermentability, and impact on host-microbiota interactions of fermented soybean meal, spray-dried plasma, yeast-derived products, insect proteins, microalgae, and novel legumes vary significantly [22] [75]. A comparative synthesis of the ingredient specific evidence is provided in Table 2.
Table 2. Comparative mechanistic evidence and practical positioning of alternative protein sources to mitigate post-weaning diarrhea in piglets.
Protein
source |
Dominant
mechanistic profile |
Evidence across the
five mechanistic domains |
Direct evidence for
reducing PWD |
Main limitations |
Evidence-based
practical
positioning |
References |
Fermented
soybean
meal |
Predominantly
digestibility-driven,
with secondary
microbial, barrier,
and immune effects. |
Digestibility:
moderate-strong but
product-dependent;
hindgut fermentation:
moderate-strong;
microbiota:
moderate-strong;
barrier integrity:
moderate; immune
regulation: moderate. |
Moderate evidence. Several
piglet studies report
reduced diarrhea-related
outcomes together with
improved nutrient
utilization, fermentation
profiles, microbiota
characteristics, and
inflammatory responses;
however, effects depend on
fermentation process and
product characteristics. |
Variation among
microbial strains,
fermentation
conditions, drying
procedures, residual
antigenic proteins,
peptide profiles, and
amino acid
availability. |
Suitable as a scalable
plant-based protein
component for
nursery diets when
product-specific
digestibility, amino
acid availability, and
antinutritional
factors are verified. |
[52] [57]
[65] |
Spray-dried
plasma |
Multi-level
regulation combining
high digestibility with
barrier-related and
immunological
activity. |
Digestibility: strong;
hindgut fermentation:
moderate; microbiota:
moderate; barrier
integrity: strong;
immune regulation:
strong. |
Strong evidence. Multiple
piglet studies indicate
improvements in fecal
consistency, epithelial
barrier-related responses,
immune regulation, and
recovery during enteric
challenge. These effects
should be interpreted
within specific
experimental and
production contexts. |
High cost, animal
origin,
source-dependent
composition,
biosafety
requirements, and
reduced economic
justification beyond
the immediate
post-weaning period. |
Strategic use during
the first one to
three weeks after
weaning,
particularly in
high-risk,
antibiotic-free, or
enteric-challenge
conditions, when
economic benefits
justify inclusion. |
[58] [76] |
Yeast-derived
proteins and
functional yeast
products |
Microbiota- and
immune-oriented
activity with
nutritional
effects depending on
product form. |
Digestibility: variable;
hindgut fermentation:
moderate; microbiota:
moderate-strong;
barrier integrity:
moderate; immune
regulation:
moderate-strong. |
Moderate but variable
evidence. Some products
improve fecal consistency
and intestinal biomarkers,
whereas others show
beneficial mechanistic
responses without
consistent clinical or
growth effects. |
Large heterogeneity
among whole yeast,
live yeast, autolysates,
hydrolysates, extracts,
cell-wall fractions,
β-glucans, and
mannan-rich
products; responses
depend on dose and
structure. |
Whole or
hydrolyzed yeast
may contribute as
protein sources,
whereas purified
cell-wall fractions
are better
considered
functional adjuncts. |
[77]-[79]
Lee et al.
(2021) |
Insect-derived
proteins |
Primarily nutritional,
with possible
microbiota-,
barrier-, and
immune-modulating
activity. |
Digestibility: moderate
and species-dependent;
hindgut fermentation:
limited-moderate;
microbiota:
limited-moderate; barrier
integrity:
limited-moderate;
immune regulation:
limited-moderate. |
Limited but promising
evidence. Direct
PWD-related findings have
been reported under
specific experimental
conditions, but validation
across insect species and
commercial products
remains insufficient. |
Chitin content,
amino acid
limitations, lipid
variability, processing
effects,
rearing-substrate safety, contaminants,
regulation, and
inclusion-level
effects. |
Appropriate for
partial protein
replacement at
moderate,
product-specific
inclusion levels;
not yet sufficiently
validated as a
primary
PWD-control
strategy. |
[80] [81] |
Microalgae |
Protein-rich
functional
ingredients with
species- and
dose-dependent
nutritional,
antioxidant, and
intestinal effects. |
Digestibility: variable;
hindgut fermentation:
limited; microbiota:
limited-moderate;
barrier integrity:
limited; immune
regulation:
limited-moderate. |
Limited and
species-dependent
evidence. Effects of
Spirulina and Chlorella
interventions on
diarrhea-related outcomes
and intestinal responses
require interpretation
according to species,
processing method, and
inclusion level. |
Resistant cell walls,
nutrient accessibility,
cost, palatability,
inclusion-related
growth effects, and
potential
contaminant
accumulation. |
Currently more
suitable as a
low-dose functional
ingredient than as
a major protein
replacement until
digestibility and
PWD-related
efficacy are further
established. |
[82]-[84] |
Novel
legume
proteins |
Regional protein
replacement with
effects mainly
determined by
processing, amino
acid balance, and
fermentable
carbohydrate
fractions. |
Digestibility: moderate
after processing; hindgut
fermentation: variable;
microbiota: variable;
barrier integrity: limited;
immune regulation:
limited. |
Very limited evidence.
Most studies evaluate
growth performance,
nutrient digestibility,
morphology, or microbial
activity rather than direct
PWD reduction under
standardized challenge
conditions. |
Protein quality
limitations, cultivar
variability, trypsin
inhibitors, lectins,
tannins,
vicine-convicine,
alkaloids, phytate,
oligosaccharides, and
fiber encapsulation. |
Suitable for partial
soybean meal
replacement after
appropriate
processing, amino
acid balancing,
and verification of
cultivar-specific
antinutritional
factors. |
[85]-[87] |
Note: Strong evidence indicates repeated findings from independent piglet studies including direct clinical or well-supported mechanistic outcomes. Moderate evidence indicates generally supportive findings with heterogeneity among products or conditions. Limited evidence indicates few studies, incomplete mechanistic assessment, or inadequate replication. Variable evidence indicates responses strongly influenced by product form, processing method, inclusion level, or experimental context. Direct PWD efficacy should ideally be evaluated using diarrhea outcomes together with growth, microbial, metabolic, epithelial, and immune measurements.
Some ingredients work primarily via upstream nutritional mechanisms, such as increasing protein digestibility and decreasing protein entering the hindgut. Others, on the other hand, have other effects on regulation of microbial ecology, regulation of epithelial barrier integrity, or regulation of immune-inflammatory regulation. However, the amount of evidence is also highly variable depending on the type of protein, as PWD data are scarcer for insect proteins, microalgae and some novel legumes, whereas spray-dried plasma and fermented soybean meal have more evidence published, with the data mainly relating to growth, digestibility or selected biomarkers [1] [2]. All protein sources are then evaluated from the same mechanistic aspects as detailed in Section 3, small intestinal digestibility, hindgut fermentation, modulation of microbiota, integrity of epithelial barrier, modulation of immune responses, PWD relevant clinical responses, cost, processing consistency, safety, and availability and sustainability.
Evidence appraisal used in this review. Descriptions of comparatively broad or more consistent do not reflect systematic-review conclusions that have been formally assessed for risk of bias or quantitatively synthesized. Three outcome categories are distinguished: 1) clinical PWD evidence, defined as the incidence, severity, duration or recovery of diarrhea; 2) functional/mechanistic evidence, such as intestinal permeability, host immune responses, fermentative metabolites, and microbiota measures; and 3) production/nutritional evidence, including feed intake, growth, feed efficiency and ileal digestibility. Prespecified piglet trials with direct endpoints for diarrhea provide more evidence of PWD mitigation than single biomarkers or growth benefits. When comparing ingredients, the following is taken into account: Reports from unchallenged versus ETEC-challenged piglets, Report type, ingredient or dose, size of study, and Agreement among studies. The following statements refer to relative breadth and directness of published outcomes and not a formal certainty ranking.
4.1. Fermented Soybean Meal
Fermented soybean meal (FSBM) is a product of a controlled microbial transformation of conventional soybean meal and the primary aim of the fermentation process is to reduce the levels of compounds in soybean meal that limit its nutritional value for newly weaned piglets. In fermentation process, microbial proteases break down large storage proteins to smaller peptides, and microbial metabolism removes some of the antinutrient, antigenic and non-protein nitrogen, and produces fermentation products like organic acids. Fermentation led to an increase in crude protein and amino acid concentrations, and a significant decrease in glycinin, β-conglycinin, and trypsin inhibitors, and apparent and standardized ileal digestibility of crude protein and amino acids was higher in ileal-cannulated weaned pigs when fed two commercial sources of FSBM compared with conventional soybean meal in a controlled comparison [52]. Previous feeding trials also suggested that the use of FSBM in the diet could increase nutrient digestibility, digestive enzyme activities, microbial balance, growth performance and diarrhea rate of piglets when compared to diets based on conventional soybean meal [88]-[90]. But fermentation cannot be taken as a universal means of enhancing protein quality. In another ileal digestibility study FSBM was not different in standardized ileal digestibility of most of the amino acids; however, the digestibility of lysine was lower indicating that fermentation and subsequent drying can preserve, improve, or impair nutritional value depending on the type of microbe used, fermentation conditions, heat exposure, and product standardization [54]. FSBM should then be considered as a group of processed ingredients, and as such, the suitability of this product for PWD control diets should be determined by measurements of the residual antinutritional factors, antigenic proteins, peptide distribution, organic acid and ileal amino acid digestibility.
In addition to enhancing protein digestibility, FSBM could help to mitigate PWD through a number of downstream alterations to the gut-health network. Partial replacement of conventional soybean meal with FSBM in ETEC K88 challenged piglets resulted in a decrease in diarrhea severity and inflammatory cytokine responses as well as changes in the relative abundance of Proteobacteria, Actinobacillus and Escherichia-Shigella and an increase in the relative abundance of taxa associated with carbohydrate fermentation [57]. Combined with the findings that FSBM reduces dysbiosis associated with pathogen exposure, it would seem that some of the effect is due to other mechanisms beyond the antimicrobial activity of the fermentation including the reduction in antigenic exposure, and the alteration in the delivery of substrates for fermentation. Similarly, the feeding of fermented corn, soybean meal has also been linked to enhanced duodenal & jejunal villus height, enhanced villus-height-to-crypt-depth ratio, enhanced short-chain fatty acid production and reduced incidence of diarrhea in weaned piglets, but this was dependent on inclusion level and intestinal segment studied [65]. Additionally, FSBM had also improved the antioxidant capacity, immunoglobulin concentrations and some functional parameters of the intestine in weaned pigs, suggesting that additional benefits besides the reduction of hindgut protein overflow are present [52]. But the mechanisms involved are still complex to isolate since the fermentation process modifies at the same time the antigenicity, peptide size, organic acid concentration, digestibility of nutrients and the availability of substrates for the microbes. Thus, alterations of any of these factors (cytokines, microbiota, villus morphology or tight-junction expression) must not automatically be attributed to FSBM’s direct bioactive effects. The strength of the evidence will be enhanced by studies that incorporate more than one of the ileal digestibility, fermentation metabolites, microbial function, epithelial permeability, mucosal immune responses, and clinical diarrhea outcomes in a single experimental design.
In general, FSBM could be characterized as a plant protein source centered on digestibility, which could be positively influencing the microbial metabolism, the integrity of the epithelium and immune regulation. The advantage is that it will reduce the limitations of traditional soy protein sources without compromising ease of access. However, there is no proof of the suitability of using FSBM as a single ingredient or that it could be fully substituted for all other specialty animal proteins in early nursery feeds. In two large trials with nursery pigs, the increase in feed efficiency was quadratic with the inclusion rate of FSBM, while the use of FSBM in combination with dried porcine soluble increased average daily gain, feed intake and feed efficiency compared to the use of FSBM alone suggesting that complementary use of protein formulations may be more effective than only a processed protein source [91]. The digestibility of the ileum was also found to vary between FSBM products, sometimes lower, which was partly due to lower digestibility of lysine, suggesting some drying conditions were too high or that the fermentation control did not work in an optimal manner [52] [54]. Therefore, it is important to characterize commercial and experimental FSBM products by applying minimum quality specifications on residual trypsin inhibitor activity, glycinin and β-conglycinin concentration, distribution of peptides in size, content of organic acids, viable microbial contamination, content of reactive lysine and standardized ileal amino acid digestibility. Furthermore, substrate composition, post-fermentation drying process, fermentation time and microbial strain should be disclosed, as they will have an impact on the consistency of the products and on the biological efficacy [92]. Therefore, FSBM could be a potential, viable ingredient of PWD-control diets and levels and substitution strategies might need to be tested individually on each product, nursery phase, basal diet and disease scenario.
4.2. Spray-Dried Plasma
Spray dried plasma (SDP) is a functional protein ingredient, which is animal derived, separated from the bloodstream of veterinary inspected animals, concentrated and then spray dried to a stable powder. In contrast to traditional protein ingredients, which supply mainly amino acids, SDP includes a variety of biologically active proteins including albumin, globulins (including immunoglobulin G), transferrin, peptides and other plasma proteins that may influence intestinal and immune function [93] [94]. Validated combinations of time, temperature, moisture and other manufacturing conditions are necessary for risk reduction, and controls on raw-material sourcing, hygienic handling, storage and product testing are needed; controls should be taken regarding the preservation of bioactive proteins, but there may be some variation in the end composition and activity as a function of animal species, raw material quality, processing and storage [93]. Experimental fractionation studies indicated that the immunoglobulins seem to play a major role in the effectiveness of SDP; the average daily gain and feed intake of early weaned pigs fed an IgG-rich fraction of plasma were similar to the effect of feeding complete SDP, and those fed the albumin-rich and low-molecular-weight fractions were not similarly affected [95]. However, SDP should not simply be considered as an immunoglobulin supplement, as the biological effects are likely to be a combination of the highly digestible protein and the functioning of its other components, such as the immunoglobulins, peptides and other functional components. Dietary SPA generally has a positive effect on post-weaning growth performance, with evidence from meta-analysis demonstrating that the growth performance during the immediate nursery phase when feed intake, intestinal function, and immune competence are most susceptible, is most positively affected by dietary SPA [96]. Overall, SDP is a highly digestible, multi-component functional protein that in PWD is not just about the nitrogen and amino acids that it can offer, but may also have an impact on pathogen binding ability, mucosal immunity, epithelial integrity and post-weaning feed intake.
However, the protective properties of spray-dried porcine plasma are not only due to nutrient supply but also because the ingredient has the potential of influencing the permeability of the epithelial barrier, activation of the mucosal immune barrier, pathogen-associated diarrhea, and microbial metabolism. 2.5% and 5% spray-dried porcine plasma (SDPP) decreased both ileal and colonic paracellular permeability and 5% SDPP decreased fecal scores, colonic electrogenic ion transport, mucosal tumour necrosis factor (TNF)-α and inflammatory-cell accumulation in newly weaned pigs. Additionally, levels of interferon-γ were also transiently lowered in the ileum and colon, which means that plasma supplementation can have a positive effect on barrier function, while still helping to reduce excess mucosal inflammation [58]. Previously, it was also demonstrated that spray dried porcine plasma (SDPP) modified the balance of leukocytes in the blood, Peyer’s patches and ileocolic lymph nodes, and decreased immune-cell density in the intestinal mucosa, but that the effects were relatively small in the growth aspects under the conditions of relatively low challenge of that study [97].
These effects are more obvious during enteric challenge. With ETEC K88 challenged early-weaned piglets, the diets with spray-dried porcine plasma resulted in a faster recovery from the diarrhea, less persistent shedding of ETEC bacteria, better villus structure and higher feed intake and growth rate than a pea-protein control diet, and the severe diarrhea and mortality were associated with piglets fed the unsupplemented plant-protein diet [76]. These results suggest a model in which plasma immunoglobulins and other bioactive proteins decrease exposure of the lumen to microbial antigens, restrict pathogen, epithelium interactions and dampen the inflammatory response to infection. But the pathogen binding and neutralization capacity of the various plasma products is likely to vary depending on antibody repertoire and biological activity, and may not be the same between different plasma products. Spray-dried porcine plasma can also have an effect on the microbial and fermentative results. Five per cent spray dried porcine plasma (SDPP) was shown to increase feed intake and growth, enhance the ratio of short-chain to branched-chain fatty acids and reduce the incidence of diarrhea in piglets compared to an unsupplemented control in piglets fed diets which were not supplemented with a pharmaceutical zinc oxide or in-feed antibiotics [98]. However, the changes in individual bacterial taxa should not be interpreted as the only mechanism of action since the microbial responses could result secondarily from improved feed intake, decreased inflammation, different protein digestion or different rate of delivery of substrates to the hindgut. In summary, all the evidence indicates that spray-dried porcine plasma as feed supplement is a multi-level intervention, which can promote barrier integrity, modulate immune activation, reduce intestinal dysfunction caused by pathogens and improve clinical recovery during immediate post-weaning period.
Rather than as a standard protein source for the whole of the nursery phase, spray-dried plasma would be best used as a phase specific, multi-functional protein ingredient during the most vulnerable early post weaning phase. It works best at the time of sudden weaning, underfeeding, pathogen exposure or dirty facilities or no traditional antimicrobial growth promoters. In a commercial study of 1230 nursery pigs, inclusion of 3% spray-dried Porcine Plasma in the diet from Day 0-Day 13 and 2% on Day 13-Day 26 led to an increase in overall average daily gain and average daily feed intake, with the majority of the benefit being seen in the first 13 days after weaning. Furthermore, the growth response has only been reported with pigs raised on antibiotic-free diets and plasma has added little to the use of in-feed antibiotics [99]. These results suggest that efficacy of SDP is highly dependent on the dietary background, piglet health status, number of days postweaning, and level of microbial challenge and warrant caution when extrapolating to other production systems. Also, spray-dried plasma products are not nutritionally equivalent. A comparison of two commercial sources demonstrated that the concentration of crude protein, digestible energy and standardized ileal digestibility of lysine, methionine, tryptophan and threonine differed, although both sources resulted in higher weight gain than fish meal in nursery pigs [100]. Therefore, energy, reactive lysine, amino acid digestibility, immunoglobulin concentration, ash and microbial quality values should be incorporated in feed formulation and quality assurance on a product specific basis, and not based on plasma-composition values.
Rigorous sourcing and biosafety control are also necessary as SDP is of animal origin. Experimental data show that spray drying can be used to inactivate the infectious virus of PED in contaminated plasma, but biosafety should be achieved through a combination of other measures such as collection from clinically examined animals, pooled-batch control, validated thermal processing, hygienic post-drying handling and appropriate storage, and not on spray drying alone [101]. For this reason, SDP is best defensible when strategically fed at moderate inclusion levels for the first 1 - 3 weeks post weaning, especially when part of high risk or antibiotic reduction programmers. Although it is relatively expensive, depends on animal raw material, is somewhat variable in composition and has strict biosafety requirements, it is also an ingredient with a unique ability to influence simultaneously on pathogen load, epithelial barrier function and mucosal immunity, making it a benchmark of sorts against which other protein sources can be judged.
4.3. Yeast-Derived Proteins and Functional Yeast Products
It would be wrong to consider yeast products as one homogenous group of ingredients, in terms of their composition, rate of inclusion and predominant effect, as this depends on the species of yeast and the form of the yeast biomass being processed. Whole or inactivated yeasts, such as Cyberlindnera jadinii and Saccharomyces cerevisiae, can be fed at relatively high levels as sources of single cell protein, while live yeasts, autolyzed or hydrolyzed yeasts, yeast extracts, fermentation products, cell wall fractions and purified β-glucans or mannan rich products are more commonly used as functional feed ingredients at lower rates of inclusion [78] [102]. Whole-cell yeast is a source of protein and intracellular nutrients, but because of the relatively resistant yeast cell wall, the nutrients may not be readily available without disruption of the cell, such as by autolysis, hydrolysis, or other processing. In contrast, yeast cell-wall preparations are rich in β-glucans, mannans, and mannoproteins that can affect the ability of microbes to attach, intestinal fermentation, epithelial integrity, and innate immune signaling and are biologically active as a function of the molecular structure, solubility, yeast strain, and extraction process, as well as concentration [59] [103]. In weaned piglets’ replacement of ~40% of diet protein with inactivated C. jadinii had no impact on productive performance but altered cecal and colonic microbial communities, increased the amount of propionate in the colon, and affected a population of natural-killer-cells in distal jejunal lymph nodes, showing that the yeast biomass can serve as both a protein source and a microbiota-active ingredient in piglets [102]. At lower inclusion rates, a combination of Kluyveromyces marxianus var. fragilis, Pichia guilliermondii and S. cerevisiae enhanced the number of Bifidobacterium, ileal morphometric indices, and fecal consistency, but failed to significantly affect overall growth performance, demonstrating that responses to gut health can be observed at a level that is not necessarily reflected in measurable production responses [91]. In a similar fashion, autolyzed yeast did inclusion dependent effects in weaned pigs with 1% being better at increasing several intestinal, blood and microbial indices than the higher level tested [78]. Therefore, the yeast products should be categorized and compared in terms of species and vitality, the processing method, the composition of the yeast cell wall, the nucleotide and peptide content of the product, the percentage of inclusion and the nutritional or functional purpose.
The beneficial effects seen with yeast derived products on gut health seem to be due to the polysaccharides in the cell wall of the yeast and fermentation by-products produced, and not just to providing protein alone. These mannan-rich fractions could compete with the ability of the pathogens to bind, while the β-glucans could affect microbial fermentation and pattern-recognition-receptor-mediated immune responses. In weaned pigs, supplementation with 0.05% yeast cell wall resulted in the increased villus-height-to-crypt-depth ratio, villus area, abundance of goblet cells, ileal claudins, occludin and mucin-1 expression, decreased circulating TNF-α and IL-1β at certain sampling times and increased abundance of Prevotella and Roseburia. However, improvements in ADG and reduced incidence of diarrhea were trends rather than consistently significant treatment effects and highlight the importance of favorable mechanistic biomarkers in not always resulting in robust clinical and production effects [77]. Selected yeast fractions are also shown to have a protective effect using disease challenge models. In piglets challenged with ETEC, feeding with β-glucan resulted in elevated levels of serum IgA and IgG, suppressed the increase of serum TNF-α and IL-6 induced by ETEC, maintained the villi structure and digestive-enzyme activity, and improved the expression levels of ZO-1, claudin-1, occludin and mucin-2. It also enhanced the abundance of cecal Lactobacillus, and the concentration of propionate. However, there was no significant effect on overall nutrient digestibility and the effect on post challenge growth was minimal suggesting that the main action of β-glucan is barrier and immune oriented rather than digestibility oriented [104].
Yeast polysaccharides are highly biologically active molecules, whose biological activity is dependent on their molecular structure. It was shown that both yeast and algal origin β-glucans decreased Enterobacteriaceae counts in piglets fed purified β-glucans from various sources, although their effects on volatile fatty acid and cytokine expression varied based on the source of β-glucans, their solubility, and location in the intestine. However, yeast derived β-glucan was mostly insoluble and resulted in the downregulation of a few colonic inflammatory cytokine markers, without the same fermentation profile seen with soluble algal glucans [59]. Therefore, the term “prebiotics” or “immunostimulants” should not be used alone to describe products derived from yeast. Their effectiveness is dependent on whether the product has intact cells, hydrolyzed biomass, mannans, β-glucans, nucleotides or fermentation metabolites or any combination of these fractions, and only mechanistic claims can be made for the characterized product that is being tested.
It would be better to think of the yeast-derived products as a heterogeneous collection of protein-rich and functional products determined by their product form, processing, dose, and production context rather than as a single microbiota-centered intervention. Hydrolyzed yeast fed at levels of up to 5% and 10% of the diet resulted in higher nitrogen retention, villus height in the jejunum, immunoglobulin A, acetate and propionate levels and lactobacilli counts, along with lower blood urea nitrogen, pro-inflammatory cytokines, Escherichia coli abundance and diarrhea rate in early-weaned piglets [79]. In contrast, live yeast and purified cell-wall fractions are used at lower levels and mainly have a microbial, fermentative and immunological action. In nursery pigs, for example, live Saccharomyces cerevisiae supplementation decreased feed efficiency, serum immunoglobulin and the number of volatile fatty acids in the feces, and the incidence of diarrhea, but the effect was influenced by whether it was fed with or without zinc oxide [105]. There is still conflicting evidence, however. In a recent experiment with 360 weanling pigs, the 2% - 6% (increased by 1% increments) inclusion of a hydrolyzed yeast product was found to improve fecal dry matter during the early nursery phase, but to have no effect on ADG or feed intake; only the lowest level tested was associated with improved feed efficiency, and the product did not fully mimic the response seen with carbadox [106]. This variation is likely to be due to a combination of differences in yeast strain, yeast viability, method of hydrolysis/autolysis, the structure of the yeast (β-glucan, mannan), amount of yeast included, basic feed, challenge level and age of piglets. Combined interventions also suggest that the yeast components might be more effective as a part of combination treatments; a combination of yeast (β-glucan) and milk hydrolysate was shown to reduce post-weaning diarrhea and was suggested as an alternative to the use of pharmacological zinc oxide, although it is not possible to determine the role of the yeast component in this case [107].
4.4. Insect-Derived Proteins
Insect ingredients form a diverse group of ingredients whose nutritional value can vary greatly depending on the insect species, developmental stage, rearing substrate and conditions, and harvesting and post-harvest treatment. The main species studied as a protein source for weaned piglets are black soldier fly larvae (Hermetia illucens), yellow mealworm (Tenebrio molitor) and lesser mealworm (Alphitobius diaperinus). The composition of their meals varies significantly in crude protein, lipids, minerals, amino acids, chitin and fatty-acids content thus the results obtained with one species or product cannot be extrapolated to all insect-derived proteins. Whilst full-fat black soldier fly larvae meal is protein-rich, defatting will increase the protein concentration relative to the meal and result in a dietary energy density shift. Black soldier fly larvae also possess chitin in the exoskeleton and have relatively high levels of medium-chain fatty acids, specifically lauric acid, which could impact nutrient digestion, microbial ecology and immune function. The concentrations and biological availability of these components, however, depend on the larval diet and the processing and functional effects cannot simply be deducted from the ingredients. The digestible protein content of the black soldier fly larvae meal is appreciable, as per available pig data but the utilization of amino acids is not uniform and is not reflected by the crude protein content alone. In growing pigs, the standardized ileal digestibility of crude protein and lysine of full-fat and defatted black soldier fly larvae meals were around 81% and 88%, respectively, indicating that the defatting did not necessarily increase the digestibility of all amino acids [108]. However, methionine needs special consideration, as in a follow-up study, the metabolic availability was less than what was expected based on the standardized ileal digestibility data, so that the ileal disappearance may overestimate the available proportion for protein synthesis [109]. Black soldier fly larvae meal can also be somewhat low in sulfur-containing amino acids, and, thus, careful formulation and supplementation with crystalline amino acids may be required when it is used as a substitute for traditional protein ingredients. The results suggest that digestibility of ileal amino acids, metabolizable amino acids, reactive lysine, chitin content and energy content should be determined for each insect product before formulating diets based on crude protein content.
Furthermore, there is comparative evidence available which shows the influence of species and processing on the suitability of the insects as part of nursery foods. The growth performance of the defatted meals of black soldier fly larvae, yellow mealworm, or lesser mealworm when they were added to balanced diets at expense of most of the enzyme-treated soybean meal were not different compared to the control. But plasma diamine oxidase concentrations were lower in the mealworm diets than in the black soldier fly diet, indicating that it may be species specific, as to how the epithelial-barrier reacts [80]. Thus, it is important to acknowledge that insect meals can be considered as nutritionally viable alternative protein sources with potential functional components, but their ability to alleviate PWD should be supported by direct measurements of diarrhea, fermentation metabolites, microbiota activity, epithelial barrier integrity and mucosal immunity and not just by their sustainability profile and chemical composition.
Based on current evidence, some of these insect meals might have an impact on some of the mechanistic pathways involved in PWD, but the effect is highly dependent on the insect meal type, the insect species, the inclusion level and the challenge conditions. In a challenge study with ETEC K88, no significant difference in piglet growth performance was observed between fish meal replacement with 4% or 8% full fat H. illucens larvae meal during the challenge period, with 50%, 37.5% and 25% post challenge diarrhea observed in control, 4% and 8% groups, respectively, and higher concentrations of Lactobacillus and lower numbers of Streptococcus observed in the fish meal replacement groups. Furthermore, the supplemented piglets had improved preservation of the villus architecture at the ileum, increased levels of occludin, claudin-3, and IL-10 expression in the mucosa and decreased levels of mucosal TNF-α expression, indicating coordinated protection of the microbiota, barriers and immune system during ETEC exposure [81]. While these observations are associated with inclusion, group denominators, numbers of affected piglets, case definition for diarrhea and between-group p-values and confidence intervals are not provided by the present review. Thus, percentages are merely descriptive and their presentation as statistically significant reduction of percentage should be checked in the primary study [81]. The small number of samples analyzed by small molecules and short post-challenge observation period also hampers conclusions concerning durability and commercial efficacy.
The dose dependence for the black soldier fly larvae meal is also high. A graded replacement experiment with 180 weaned piglets showed that about 25% replacement of soybean meal with black soldier fly larvae meal resulted in an increase in average daily gain, feed intake, digestibility of dry matter and organic matter, villus height: crypt depth ratio in duodenum, sucrase activity in jejunum, ileal levels of IgA, IgG and IgM, and abundance of several short-chain-fatty-acid-producing bacterial groups. Meanwhile, 75% - 100% replacement resulted in growth performance reduction and 100% replacement led to increased levels of potentially harmful bacteria with no improvement in tight-junction protein expression [110]. Part of the negative response at high inclusion was attributed to low intrinsic chitin-degrading ability despite the fact that the expression of chitinase was not significantly affected. These findings indicate that moderate incorporation can have a favorable effect on digestive and microbial activities while high incorporation can increase the physiological stress due to chitin, lipids, mineral or amino acid imbalance.
Insect species vary in their responses, as well. All three of the protein sources (defatted black soldier fly larvae, yellow mealworm, and lesser mealworm meals) performed well when used as a substitute for the majority of an enzyme treated soybean protein source over 14 days. But only the group fed with the yellow or lesser mealworm showed lower levels of circulating diamine oxidase, indicating less intestinal mucosal injury, while the black soldier fly larvae meal mainly led to an increase in the proportions of lactic acid in the small-intestinal digesta and did not significantly affect levels of IgA, D-lactate, total colonic short-chain fatty acids, or enumerated lactobacilli or enterococci [80]. As a whole, these studies suggest that insect proteins could impact PWD via disruption of gut microorganisms, fermentation, epithelia barrier function and immune modulation, but fail to reveal a consistent “insect-protein effect.” The potential functional constituents such as lauric acid, chitin or chitosan, and antimicrobial peptides are still viable players, but they have seldom been tested independently from the protein replacement, dietary fat, processing and amino acid reformulation. Mechanistic claims should therefore be limited to the respective insect product and inclusion rate tested.
At present, insect proteins are best suited as nutritionally sound and yet mechanistically less validated ingredients which should be tentatively used as inclusion to the extent of moderate percentage in a product, rather than as a replacement of conventional proteins. Available evidence suggests that selected black soldier fly larvae meals can sustain growth performance and might promote the microbial composition, barrier-associated biomarkers, immune responses and diarrhea outcome, especially when challenged with ETEC. But, not all these studies, nor all insect species, always replicate these benefits. Dose-response evidence indicates that substituting black soldier fly larvae meal for about 25% of soybean meal enhances growth performance, nutrient digestibility, gut morphology, immunoglobulin concentrations and specific short-chain-fatty-acid-producing bacteria, while replacing at 75% - 100% reduces growth and results in less favorable microbial responses [110]. Likewise, defatted black soldier fly, yellow mealworm and lesser mealworm meals were able to maintain the performance of the enzyme-treated soybean protein, but the benefits associated with these barriers were more evident for the two mealworm meals than for black soldier fly larvae meal [80]. All these results indicate that efficacy varies depending on insect species, developmental stage, rearing substrate, lipid extraction, heat processing, concentration of chitin, fatty-acid profile, amino acid balance, and the level at which insects are included in the diet; hence, the use of the term “insect protein” should not be understood as a description of a functionally uniform ingredient.
However, the sustainability benefit of insect meals has to be understood with a grain of caution. Life cycle assessment suggests that the environmental performance is significantly influenced by the rearing substrate, energy for larval production and drying, transport and environmental burden allocated to residue management. While it can be superior in certain impact categories, it cannot be assumed that production of black soldier flies with agro-residues is superior to soybean meal, fishmeal or conventional residue-treatment systems in all environmental impact categories [111]. Feed safety is also substrate dependent as larvae may be able to concentrate certain minerals and contaminants from the substrate used for raising them; this requires validated feed and substrate controls and regular monitoring of potentially harmful minerals and microbial hazards [112] [113]. Therefore, the species of insects, the larval stage, the rearing substrate, the processing and defatting procedure, the amino acid composition, the crude protein content, the standardized ileal digestibility, the reactive lysine content, the chitin content, the content of lipids, such as lauric acid, other lipid fractions, the ash content, the content of contaminants and the microbiological quality should be reported in commercial evaluation. Although at present, insect meals are considered to be a potential source of sustainable protein and may have barrier-, microbiota-, and immunomodulatory properties, the evidence available to support consistent PWD prevention is far less robust than that for spray-dried plasma and fermented soybean meal.
4.5. Microalgae and Novel Legume Proteins
It is important to note that the microalgae and cyanobacterial biomasses cannot be considered as a single class of protein, as their nutritional and functional characteristics differ significantly depending on the species, growth conditions, harvest methods, cell wall composition and following processing. Arthrospira platensis (Spirulina) and Chlorella vulgaris are the most investigated microalgal ingredients in weaned piglets. Besides protein, these biomasses also have varying amounts of polysaccharides, lipids, pigments, vitamins and minerals, and other bioactive components that can impact nutrient assimilation, microbial communities, oxidative balance, and immunity. But resistant cellular structures may limit the accessibility of nutrients, and digestibility or biological efficacy is strongly dependent on both the inclusion level and the processing methods, especially the recalcitrant cell wall of Chlorella and the complex architecture of the cell-envelope of Arthrospira [84]. Microalgae have shown species-specific gastrointestinal response with relatively low dietary inclusion levels. Average daily gain, feed intake, and feed efficiency of weaned-pig finishing diets were not significantly affected by supplementation of weaned-pig diets with 1% Spirulina or 1% Chlorella, but supplementation of both ingredients increased the villus height of the jejunum and improved selected nutrient-digestibility indices. Significantly, the number of piglets with diarrhea decreased in the Chlorella fed group but not in the Spirulina fed group, suggesting different clinical effects of the same class of composition [82]. A separate study where the microalgae was fed orally, before and after weaning, it was found that Spirulina decreased the incidence of post-weaning diarrhea by ~50% while neither microalga consistently increased post-weaning growth, intestinal morphology or mucosal cytokine expression. The protective effect against diarrhea was then not explained by a generalized anti-inflammatory effect, but might have been caused by other mechanisms such as increased or decreased luminal conditions, microbial interactions, or bioactive components [83].
An increase in the inclusion level can help identify nutritional limitations, but conclusions need to be related to the species and experimental conditions evaluated. The reference cited [84] is about dietary Chlorella vulgaris and feed enzymes in weaned piglets, and immune and liver-metabolite outcomes, but it does not provide evidence for the claims of growth, intestinal proteomic, or metabolomic outcomes for Spirulina by itself. Accordingly, those statements relating to Spirulina have been removed until they are identified and matched with the corresponding primary source. Inferences made about chlorella should not be extended to Arthrospira platensis. Overall, these results indicated that microalgae might serve as protein-rich functional ingredients which could have an impact on intestinal development, immune status and diarrhea; however, efficacy depends on the species, dose, cell-wall accessibility and processing. However, their inclusion in PWD-control diets has not been as well established as fermented soybean meal or spray-dried plasma as relatively few piglet studies have been conducted in which both ileal amino acid digestibility, microbial fermentation, epithelial permeability, inflammatory signaling and clinical diarrhea have been measured. The species and strain, the cultivation conditions, the harvesting and drying processes, the cell-wall disruption process, the crude protein and amino acid composition, the pigment and lipid fractions, the digestibility, the level of contaminants, and the level of incorporation in the diet should therefore be included in product characterization.
Alternative protein sources to imported soybean meal are available in the region and include novel and locally adapted grain legumes, particularly field pea (Pisum sativum), faba bean (Vicia faba) and lupin (Lupinus spp.), which, depending on the amino acid balance, concentration of antinutritional factors, carbohydrate composition and processing method, might be suitable for newly weaned piglets. These legumes are generally lower in one or more essential amino acids, particularly methionine, cysteine or tryptophan, and may contain levels of trypsin inhibitors, lectins, tannins, vicine-covicine, quinolizidine alkaloids, phytate and fermentable oligosaccharides, which are present in varying amounts depending on species and cultivar. It has been revealed in an early comparative study that there were significant differences in nutrient digestibility, endogenous nitrogen losses, digestive-enzyme responses and small intestinal morphology between pea, faba bean and blue lupin, which proves that grain legumes are not nutritionally interchangeable plant proteins [114]. Processing thus is an important factor in their feeding value. Substituting extruded pea seeds for soybean meal resulted in a positive effect on average daily gain and apparent protein digestibility when compared using raw pea seeds, but had limited effects on the distal-colonic microbial activity and ileal and colonic morphology [86]. Likewise, diets with 20% - 25% extruded faba bean seeds did not affect piglet growth and did not cause any significant changes in the SCFAs, ammonia or the activity of bacterial enzymes in the large intestine, while excessive inclusion levels resulted in less favorable responses in terms of piglet performance [85].
Non-protein ingredients of legumes may also influence gastrointestinal function. In ETEC challenged piglets, pea, faba bean or hull fractions did not negatively affect the incidence of diarrhea or time of clearance of the pathogens, although it did lead to different (ileal) microbial composition, with a lower microbial richness in the faba bean-based diets than in others [115]. This is significant as fermentable starch, resistant starch, non-starch polysaccharides, oligosaccharides, and seed-coat fractions could change the microbial fermentation independent of the protein fraction. More recently, a processed pea co-product was found to undergo rapid protein hydrolysis with no loss of barrier function of IPEC-J2 cells [116] but these preliminary results were obtained from simulated digestion and cells rather than a feeding study with piglets and challenge with ETEC. Furthermore, purified pea protein has been seen to be less successful as the key protein ingredient in certain ETEC-challenge models, without the addition of protective functional ingredients, thus demonstrating that the purity of the plant protein is not necessarily a determinant of PWD resistance [76]. At present, protein from peas, faba beans, lupins and other legumes should therefore be viewed as context dependent and the effects on PWD should not be interpreted as being a “naturally protective” effect of protein from legumes but as an effect of the interplay of protein digestibility, residual antinutritional factors, fermentability of fiber and starch, supplementation with amino acids and processing.
Microalgae and novel legumes should be targeted as emerging protein alternatives in a context-dependent rather than as proven functional proteins for PWD. Microalgae can supply high levels of protein, along with pigments, polysaccharides, polyunsaturated fatty acids, vitamins and antioxidant molecules, however with significant species-specific differences, inclusion rate, accessibility of the cell wall and processing. Some studies of piglets have reported results of microalgal supplementation that differ in terms of diarrhea or digestive outcomes depending on the species, formulation and inclusion level [82] [83]. Immune and metabolic variables included in findings from Chlorella in reference [84] cannot be considered as direct evidence of lowered PWD. However, the lack of consistency suggests that the microalgal biomass may not be useful as a highly digestible protein and as a gut-health additive simultaneously. It could also be applied in low dose functional supplementation, and in higher level protein replacement; both of these are to be assessed.
The novel grain legumes will be easier to incorporate into practical feeds and value will depend on the cultivar composition and the physical availability of these nutrients. Intact cell walls in peas can bind intracellular protein and decrease ileal protein hydrolysis, but artificial damage to the structure of plant cells resulted in an increase in protein hydrolysis of about 19%, independent from crude protein level [117]. The response of faba-bean is also genotype dependent. Among five cultivars, for weaned pigs, differences in feed intake and growth were more associated with the levels of vicine and covicine, than with condensed tannin concentration alone, and overall, nutritionally balanced diets of up to 30% faba bean tended to maintain growth rates and similar fecal consistency despite some decreases in energy digestibility and dry-matter digestibility [87]. Recent ileal-cannulation evidence also indicates that steam pelleting and extrusion can enhance the apparent and standardized ileal digestibility of several AA in faba bean, thus thermal processing can enhance its nutritional value but cannot do so equally with all the AA [118].
Accordingly, microalgae and legumes should be evaluated using product-specific criteria that include species or cultivar, antinutritional-factor profile, cell-wall structure, processing method, standardized ileal amino acid digestibility, fermentable carbohydrate content, contaminant status, and inclusion level. The central evidence gap with PWD mitigation is not whether these ingredients can partially replace the soybean meal, but if they consistently mitigate diarrhea by measurable increases in fermentation, microbiota function, epithelial barrier integrity and mucosal immune function. Microalgae and novel legumes are considered to be promising sustainable protein sources with more or less and variable direct effects on PWD until appropriate powered piglet studies are available that take these mechanistic outcomes into account and also include direct measures of diarrhea, preferably under ETEC challenge. Table 2 provides an overview of comparative nutritional, mechanistic and practical features of the various alternative protein categories mentioned in Section 4.1 - 4.5.
4.6. Functional Complementarity and Ingredient-Selection
Framework
The comparative evidence suggests that none of the alternative protein sources are consistently able to target all mechanisms of PWD. Therefore, the protein source chosen should be determined by the predominant biological limitations of the production system, and not by protein content and/or a general ranking of protein sources. Depending on the main issues involved such as poor protein utilization and high hindgut N flow, highly digestible or properly processed proteins might be preferred, while in other cases, such as high pathogen challenge or inflammation of the gut, ingredients with enhanced barrier-protective and immunomodulatory effects might be favored. Functional yeast products can be used as a protein diversification source when there is microbial instability and insect proteins, microalgae and new legumes, if sufficiently characterized for digestibility, safety, processing and level of inclusion, can complement to diversify protein.
Hence, it may be more appropriate to adopt a phase-specific approach instead of a general replacement with one ingredient. Formulations should be high digestible at the ileal level, low antigenicity, palatable and include substances that support the function of the epithelium and immune system during the immediate post-weaning period and then use more economical or sustainable protein sources progressively as gastrointestinal competence develops. Finally, efficacy of ingredients should be assessed based on clinically meaningful parameters such as incidence of diarrhea, severity of diarrhea, feed intake, growth, need for treatment, mortality, etc. and inflammatory and barrier markers should only be used to help explain the clinical responses [1] [99].
5. Future Research Priorities and Translational Challenges
The differences in the age of the piglets, the target feed composition, the processing method, the dose and duration of the trial, the pathogen challenge, and the definition of the response (e.g., nutrient digestibility or intestinal morphology) mean that it is difficult to draw general conclusions and to establish a ranking in terms of efficacy for the selected alternative protein sources after weaning [1] [5] [92] [96]. The priorities listed below tackle these sources of heterogeneity.
5.1. Standardized Ingredient Characterization and Reporting
The development of Minimum Analytical and Reporting Standards for alternative proteins ingredients is a big research focus. Ingredients can be broadly labelled, with significant variation in the raw material properties, nutrient digestibility, bioactive content, antinutritional factors and processing conditions, impacting on the reproducibility and cross-study comparison of the products [53] [92]. Therefore, the biological species/cultivar, raw material source, ferment or organism/rearing substrate, processing method, thermal treatment, drying method, storage time and inclusion level in the feed should be mentioned in studies. Nutrient characterization shall be based on crude protein and amino acid content, ileal digestibility of amino acids (IDA), content of reactive lysine, energy value, ash, fiber fractions and other indicators of ingredient quality. For products in which the ingredients are defined, some other functional components such as remaining trypsin inhibitors, glycinin, β-conglycinin, lectins, tannins, alkaloids, chitin, cell wall polysaccharides, immunoglobulins, β-glucans, mannans, nucleotides, organic acids, peptide-size distribution, etc., should also be measured according to the product type [53] [92]. Microbial quality, mycotoxins, heavy metals, pesticide residues, and substrate-derived contaminants (especially for insect meals, microalgae and industrial co-products) should be included in the safety characterization. This product-specific approach is highlighted by commercial evidence that different nursery-pig responses were obtained from differing specialty soya proteins, with identical ileal digestible lysine contents [119]. The use of a standard reporting checklist would facilitate comparisons between studies, allow meaningful meta-analyses, and the separation of true biological differences from lack of reporting of differences in ingredient quality.
5.2. Head-to-Head Comparisons and Combination Strategies
Studies cited in the present document were mostly conducted to investigate the differences in the individual alternative protein sources compared to the traditional soybean meal, with differences in one alternative protein source compared to another under the same nutritional and health conditions being relatively limited. Future comparative trials need to be conducted with diets containing equivalent metabolizable energy levels and standardized for ileal digestible amino acids and other dietary factors that could affect the results, such as acid binding capacity and fiber [53] [119]. This control has to be there to separate out any effects that are due to the protein ingredient from any effects due to differences in nutrient supply or diet composition. However, it is important that studies differentiate protein replacement effects from low dose functional supplementation and that appropriate factorial design is used for assessing the combination of ingredients, and whether the responses are additive, synergistic or antagonistic [1].
In combination studies, treatment groups should consist of each ingredient alone, the combination and an adequate balanced control to assess additive, synergistic or antagonistic effects [91] [107]. The primary outcomes should be clearly defined as diarrhea incidence, severity, therapeutic-treatment needs, mortality, removals, feed intake, growth and feed efficiency. As explanatory outcomes, microbiota, permeability and immune biomarkers should not be used as a replacement for clinical benefit; improved performance or biomarkers do not necessarily equate with PWD prevention [120] [121].
5.3. Integrated Mechanistic and Multi-Omics Validation
Future mechanistic investigations should account for the five pathways summarized in this review, and should not view digestion, the microbiota, barrier function and immunity as separate outcomes. There is evidence for the simultaneous modulation of intestinal microbial composition and metabolomic profile by dietary protein in post-weaning piglets [56] and these can be combined with molecular and histological methods to provide added explanatory value if the primary experimental model is appropriately identified. The complete experimental design should therefore include the ileal digestibility of amino acids and the flow of undigested nitrogen, in addition to the measurement of fermentation metabolites, microbial functional capacity, epithelial permeability, intestinal morphology, and mucosal immune signaling. Longitudinal sampling and integrated data analysis should be considered as a prospective study-design priority to differentiate the changes that occur before the onset of diarrhea and those that occur after reduced feed intake or onset of disease; this is a recommendation, not a demonstrated result of removed citations. Simple and reproducible biomarkers should also be associated to the multi-omics datasets that will be helpful and interpretable in the future for commercial feed evaluation, for example, and not merely descriptive molecular signatures [2] [75].
5.4. Dose, Age, and Phase-Specific Optimization
Some alternative proteins sources have been reported to have dose- and phase-dependent responses in weaned piglets. Moderate levels of inclusion may have a positive effect on the function of the intestine or growth, while high levels may have a negative effect on digestibility of nutrients and/or performance as observed for microalgae and insect meals [82] [110]. Future studies should therefore be conducted using graded-dose designs, to determine lower, optimal and upper tolerable levels of inclusion, and express inclusion levels as a percentage of the complete diet as well as a percentage of the replacer protein. Weaning age, initial body weight, feed intake, dietary protein and amino acid supply, fiber content and pathogen pressure should also be taken into account when interpreting a dose-response. The physiological response to some functional proteins may vary within the different phases of the nursery; spray dried plasma typically is most effective during early post-weaning phase and in higher health challenge [99].
5.5. Commercial Validation, Economic Feasibility, Sustainability,
and Biosafety
Future commercial validation experiments should include sample sizes justified by the experiment, clearly defined experimental units, and production conditions that reflect the variability of herd health, hygiene, management and antimicrobial use in the real world to increase the external validity of the results. As in other animal experimental designs [122] the feeding environment may be considered as the experimental unit with pen-level data for dietary treatments. Commercial scale nursery trials using large numbers of pigs have shown the potential and need to validate dietary treatments on a larger scale under practical production conditions [99]. Multi-site studies should also evaluate the reproducibility of treatment responses, where feasible. Outcomes of commercial evaluations should include clinically and economically relevant parameters such as mortality, removals, therapeutic-treatment requirements, feed intake, growth, feed efficiency, and feed cost per unit gain [123]. Recent large-scale testing of specialty soy proteins has shown that commercial testing can yield results that deviate from those anticipated in small experimental tests and can show interactions with acid binding capacity and pharmacological zinc oxide [119]. When assessing economics, it is important to take into account the total inclusion rate in each phase, feed intake, savings from the reduced treatments, value of the reduced dependence on antimicrobial use and mortality adjusted output.
Similarly, sustainability claims should not be presumed based on novelty or the fact that an ingredient is not a soy ingredient. The elements which influence environmental outcomes are the Land use, Energy needs, Transport, Drying, Rearing of the substrate, Recovery of nutrients and Allocation of environmental burden to co-products. For instance, the sustainability of insect meal is highly dependent on the type of substrate used to produce the larvae, and the energy needed to process the meal, and microalgal protein has a significant energy cost associated with its growth, dewatering and drying [74] [116]. Evaluation of biosafety must be done in parallel to nutritional and functional efficacy. Controlled sourcing and validated multiple-hurdle manufacturing procedures, such as appropriate processing and post-processing controls [93]. are critical to feed safety when the plasma is from animal sources. The rearing substrate determines the risk of contamination when it comes to insect meals, therefore substrate selection and management of potential contamination, such as heavy metals or mycotoxins, is crucial [117]. The quality monitoring should also be product-specific as the nutritional profile and the presence of contaminants of commercially-grown Chlorella and Spirulina might vary from producer to producer, or from one production lot to another [124]. Therefore, alternative protein sources are only considered to be practically beneficial when they demonstrate nutritional and functional efficacy, acceptable feed safety, compliance with regulations, supply continuity, environmental performance and economic viability.
6. Conclusions
Post-weaning diarrhea is a systems-level disease resulting from the interplay of under-development of the gut’s digestion, increased protein fermentation in the hindgut, altered microflora, damage to the intestinal epithelia, inflammation of the epithelia and secretion by ETEC. As the protein is a key component of this network, the digestibility, antigenicity, fermentability and bioactive composition of dietary protein affect both amino acid availability to the developing piglet and the nature of the substrates and signals for the gastrointestinal microbiota and mucosa. Alternative protein sources should thus be assessed within these five interrelated domains: small intestinal digestibility, hindgut fermentation, microbiota composition and metabolic function, integrity of the intestinal barrier and immune-inflammatory regulation.
The data presented herein show that alternative proteins have different functional characteristics. Fermented soybean meal’s main mode of action is the reduction in the presence of antinutrients in soybeans or the enhancement of protein utilization, though its effectiveness is highly dependent on the quality of the fermentation and drying of the product. Spray-dried plasma is most consistently found to benefit feed intake, epithelial integrity, immune regulation, and recovery from enteric challenge, but may be expensive, of animal origin, and require biosafety guidelines for its use, which makes it attractive for use during the early phase. The beneficial activities of yeast-derived components can help maintain the homeostasis of the microorganisms and immune system, although they vary significantly between whole-cell biomass, hydrolysates, cell-wall fractions, β-glucans, mannans and live cultures. While there is potential for protein diversification and sustainability in use of insect meals, microalgae and novel legumes, there is relatively little direct and replicable proof of their use for PWD control. None of the ingredients is the best regulator for all the pathways associated with PWD. A phase-specific and complementary approach is thus the most defensible: digestibility at the outset of the phase, followed by a selection of functional ingredients to maintain stability of the microbiota, repair of the epithelium and immune balance. Appropriate and future recommendations should be based on standardized ingredient characterization, head-to-head comparison, integrated mechanistic validation, dose-response optimization, commercial trials, and simultaneous economic, environmental and biosafety assessment. The composition of ingredients based on their biological function and their production environment provides the greatest foundation for producing effective nursery diets that will have the greatest impact on the health and performance of piglets and the ability to minimize reliance on antibiotics and pharmacological zinc oxide.
Ethics Approval and Consent to Participate
Not applicable. This manuscript is a review article based on previously published studies and does not report any new experiments involving humans or animals.
Consent for Publication
Not applicable.
Availability of Data and Materials
Not applicable. No original datasets were generated or analyzed in this review article. All information discussed is derived from previously published studies, which are appropriately cited in the reference list.
Funding
This work was supported by the China Agriculture Research System (CARS-41), the RDA-CAAS Collaborative Project (PJ017897), and the State Key Laboratory of Animal Nutrition and Feeding (2004DA125184G2602).
Acknowledgements
The authors gratefully acknowledge the financial support provided by the China Agriculture Research System (CARS-41), the RDA-CAAS Collaborative Project (PJ017897), and the State Key Laboratory of Animal Nutrition and Feeding (2004DA125184G2602).
Author Contributions
M. Chantal Nzeyimana: Conceptualization, literature search, data curation, visualization and writing original draft preparation; Dieudonné Nsengiyumva: Literature analysis, writing, review and editing; Constantin Nimbona: Literature analysis, writing, review and editing; Napoleon Munyaneza: Literature analysis, writing, review and editing; Bao Yi: Writing, review and editing, supervision; Zhong Ruqing: Writing, review and editing, supervision; Liang Chen: Supervision, project administration, and funding acquisition; Zhang Hongfu: Supervision, project administration, and funding acquisition.
All authors have read and approved the final version of the manuscript.